Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Teva acquires drug delivery company MicroDose Therapeutx for $40mm up front

Executive Summary

Teva Pharmaceutical Industries Ltd. has paid $40mm up front for MicroDose Therapeutx Inc., a private maker of inhalation and oral drug delivery systems. MicroDose is also eligible for up to $125mm in development and regulatory earn-outs, plus undisclosed sales milestones and tiered royalties tied to commercialization of the company’s lead candidate MDT637 and an early-stage asthma/COPD program.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
      • Transdermal
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register